Chicken embryos were used to investigate the mechanism by which viridans streptococci inhibit the growth of pathogenic staphylococci. Ten-day-old embryonated eggs were infected allantoically. At a concentration of 1.8 x 102 colony-forming units (CFU) of viridans streptococci, the percentage of fatalities was less than 10%. There was 80% fatality with 8 x 10' CFU of Staphylococcus aureus strain 502A and 100% when a 100-fold increase in concentration was used. An inoculum size of 102 to 103 CFU of viridans streptococci was chosen to protect the embryos against the lethal effect of strain 502A when challenged 24 h later. The survival after challenging at 4 days was 93% in protected eggs and 37% in unprotected eggs. Chicken embryos receiving heat-killed viridans and challenged with strain 502A when examined after 4 days did not demonstrate a protective effect. This protection of embryonated eggs could not be transferred by administration of sterile filtrate of allantoic fluid in which protecting strain was grown. The experimental infection of embryonated eggs has demonstrated that prior allantoic infection with viridans streptococci affords significant protection against subsequent challenge with virulent staphylococci.
The normal bacterial flora of man exert a protective effect against certain pathogenic bacteria. Some strains of viridans streptococci of the oropharynx inhibit the growth of enteric bacteria (13) , other streptococci (10) , and pneumococci (4) . Although the importance of bacterial interaction in the host is recognized, the mechanism is poorly understood. We have observed that certain strains of viridans streptococci isolated from the nose of normal subjects inhibit Staphylococcus aureus and Streptococcus pyogenes when grown together on Trypticase soy agar (TSA). This study was designed to gain further insight into the factors controlling bacterial interference, specifically the protective effects of viridans streptococci against lethal strains of S. aureus in embryonated eggs.
MATERIALS AND METHODS
Chicken embryos. Ten-day-old embryonated eggs were infected intra-allantoically and incubated at 37 C; the time was adjusted for each experiment. All eggs were injected with 0.1 ml of bacterial suspension unless otherwise mentioned.
Protecting strain. Avirulent streptococci (in smaller doses, < 10' colony-forming units [CFU ] ) were used as protecting or interfering strains for chicken embryos. Several strains of viridans streptococci isolated from the nose and throat of normal subjects were tested on TSA by utilizing modified techniques of Sanders (10) . Strains inhibiting growth of S. aureus on TSA were thus included. The strain utilized as an interfering strain grows on sheep blood agar and produces alpha-hemolysis. Optochin and bile solubility tests were also performed. The organisms were grown in Ts broth at 37 C for 24 h and were diluted in physiological saline for appropriate concentrations.
Challenge strain. S. aureus strain 502A is consistently virulent to embryonated eggs and has been utilized as an interfering strain against staphylococcal infections in humans (11, 12) . This strain of S. aureus produces golden yellow, beta-hemolytic colonies on sheep blood agar and is coagulase and mannitol salt positive. Strain 502A is sensitive to penicillin G (0.05 jsg/ml) and resistant to tetracycline (25 jig/ml Fig. 1) . At a concentration of 1.8 x 102 of viridans streptococci, the survival rate was more than 90%. The survival rate decreased to 10% when 107 CFU of viridans streptococci was injected. There was 25% survival with 6 .8 x 101 CFU of strain 502A; this decreased to 0% when a 100-fold-increased concentration was used.
Protection effect of the number of viridans streptococci against lethal infection of strain 502A. Ten-day-old embryonated eggs were injected with viridans streptococci in 0.1 ml of physiological saline (2.2 x 10' to 107 CFU). Twenty-four hours later, each group of embryos was challenged with 2.4 x 102 CFU of strain 502A and was observed daily. Maximal protec- (Table 4 ). Another group of eggs received saline only. No statistically significant protection was afforded in the eggs previously injected with filtered, infected allantoic fluid (15% survival) when compared with embryos which received uninfected allantoic fluids (10% survival; P = 0.5).
The filtered, infected allantoic fluids (3 x 108 CFU of viridans streptococci per ml before filtration), filtered, uninfected allantoic fluids, and infected allantoic fluids containing 3 x 108 CFU of viridans streptococci per ml were transferred to small glass tubes in 4-ml volumes. The tubes were inoculated with strain 502A (102 CFU) in a 0.1-ml volume and incubated at 37 C. Samples of allantoic fluid were subcultured on blood agar plates at 0, 6, 16, and 24 h after addition of 502A. Bacterial counts were performed on each blood agar plate (Table 5) . The values listed represent the means of two duplicate sets of experiments. Strain 502A count in filtered allantoic fluids previously infected with viridans streptococci did not differ from that of uninfected fluid (1.2 x 1010 CFU/ml for infected and 4 x 1010 CFU/ml for uninfected fluids).
However, the number of S. aureus recovered from the unfiltered infected fluids was much less than recovered from the filtered fluids (2.6 x 105 and 1.2 x 1010, respectively). The number of viridans streptococci present at 0, 6, 16, and 24 h were 2.8 x 108, 2 x 108, 108, and 6.7 x 107 CFU/ml, respectively.
DISCUSSION
Clinical observations suggest that bacterial interference contributes to the host defense system. This mechanism has been used to abort staphylococcal infections in newborn nurseries and in recurrent furunculosis (6, 11, 12, 14) . Alpha-hemolytic streptococci have also been shown to inhibit the growth of pathogenic bacteria in the oropharynx (4, 10) . Although the phenomenon of bacterial interference is well established, the mechanism is poorly understood. The present study substantiates a part of this phenomenon and provides a convenient tool to study bacterial interference experimentally. It was shown that prior intra-allantoic infection of chicken embryos with viridans streptococci protected them from the virulent strain of 502A. An inoculum size of 1. Several mechanisms by which one organism inhibits the growth of another are known. These include: exhaustion of essential nutrients (3, 15) ; production of antibiotic (9) or bacteriocin (1, 2); and nicotinamide depletion resulting from bacterial growth in Trypticase soy broth (7) . In other studies, infection of chicken embryos with coagulase-negative staphylococci resulted in protection of embryos from lethal effects of virulent coagulase-positive staphylo- (5) reported that protection of chicken embryos with coagulase-negative staphylococci was not only against virulent coagulase-positive staphylococci, but also against heterologous organisms such as pneumococci, salmonellae, Proteus, Escherichia coli, and one strain of influenza.
It does not seem that exhaustion of nutrients or production of bacteriocin were operative in this study, because the allantoic filtrates harvested after infection with viridans streptococci and uninfected allantoic filtrate supported the growth of strain 502A equally well. The presence of inhibitors produced by the interfering strain and the possibility of their being neutralized or destroyed by the allantoic fluid cannot be excluded. However, the data suggest that active multiplication of viridans streptococci is required to protect chicken embryos against the lethal effect of S. aureus.
